OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, today announced that it received a Notice of ...

As an expert explained in an interview with CURE, we may be in the midst of a “new era” for small cell lung cancer research.

The Food and Drug Administration (FDA) has approved Imfinzi (durvalumab) for adults with limited-stage small cell lung cancer ...

A study by researchers from the University of Liverpool and the Research Institute for Diagnostic Accuracy, Netherlands, has ...

University of Alberta researchers have developed a new molecular imaging test that could lead to improved diagnosis of lung ...

As technology advances in the fight against cancer, Allegheny Health Network is using a new robotic tool to diagnose lung ...

Cigarette smoking is by far the biggest risk factor for lung cancer, data shows — but in a surprising turn of events, the most common form of the disease is primarily found in non-smokers.

Early diagnosis of lung cancer is a critical priority in clinical practice. It may help reduce the rate of lung-cancer-related mortality, extend disease-free survival, and allow patients to live ...

There was an estimate of 1.6 million new cases of lung cancer in men in 2022, and about 910,000 cases of lung cancer in women. Researchers noted that as smoking prevalence has declined in many ...

6, 2025 — Scientists have created a new low-cost, fast response sensor to detect lung cancer ... mRNA Cancer Vaccine Shows Potential for Advanced Stage Cancer Patients in Phase 1 Trial Sep ...

Recent research published in The Lancet Respiratory Medicine confirms that emphysema was detected in 24% to 31% of patients undergoing lung cancer screening. This means that for millions of Americans, ...